BioLife Solutions, Inc. (BLFS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about BioLife Solutions, Inc. (BLFS)
Go deeper and ask any question about BLFS
Company Performance
Current Price
as of Oct 03, 2024$24.33
P/E Ratio
N/A
Market Cap
$1.12B
Description
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Metrics
Overview
- HQBothell, WA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBLFS
- Price$24.33+0.16%
Trading Information
- Market Cap$1.12B
- Float97.37%
- Average Daily Volume (1m)311,098
- Average Daily Volume (3m)337,774
- EPS-$1.45
Company
- Revenue$126.12M
- Rev Growth (1yr)-28.30%
- Net Income-$7.15M
- Gross Margin49.36%
- EBITDA Margin-1.36%
- EBITDA-$0.39M
- EV$987.66M
- EV/Revenue7.83
- P/EN/A
- P/S8.88
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset